PHARMExcel’s CEO, Yvanne Evener, will be speaking on an interactive panel at this year’s Clinical Outsourcing Group Conference UK, titled “Outsourcing in Clinical Trials: Navigating FSP Models, Partnerships, and Pricing Transparency”.
COG London 2025 is a premier event designed to support small and mid-sized biotech companies in navigating the complexities of clinical outsourcing. Taking place at the Copthorne Tara Hotel London Kensington on the 4th & 5th of March 2025, the conference brings together key industry leaders, decision-makers, and innovators to discuss trends, challenges, and solutions in clinical trial management.
For biotech companies looking to move from early-stage research to clinical trials, this event is invaluable. Attendees will gain insights from experienced professionals, network with potential partners, and explore strategies to optimize trial efficiency and regulatory compliance. Whether you are a start-up seeking guidance or an established biotech looking to refine outsourcing strategies, COG London 2025 is the place to be.
This year’s event features a distinguished lineup of industry experts, including:
Keynote Panel: Putting Patients at the Heart of Clinical Trials
A discussion on enhancing patient-centricity, diversity, and collaboration within UK trials.
Keynote: Troubleshooting Challenging Hospital Sites
Exploring common obstacles in trial setup, recruitment, and data quality.
Keynote: Navigating the UK Clinical Trial Landscape
Strategies for overcoming resource allocation, contract negotiations, and regulatory approvals.
Keynote: Navigating Regulatory Complexity
Insights into patient-centric regulatory strategies to accelerate approvals.
Interactive Panel: Outsourcing in Clinical Trials
Examining FSP models, partnerships, and pricing transparency.
Insight Session: Avoiding Pitfalls When Outsourcing Safety in Clinical Trials
Guidance on selecting and managing pharmacovigilance providers.
Case Study: Strategic Pivot in Biotech
Lessons from MediSieve’s transition from full commercialization to a partnership-focused model.
Case Study: Pioneering Women’s Health: Inside a London-Based Phase 1 Transdermal Trial
Operational insights from a multi-cohort study on women’s health.
Case Study: Strategic Site Selection for Early-Phase Trials
Financial and regulatory considerations for optimizing global site selection.
CEO Panel: Fuelling the Future: Funding Clinical-Stage Biopharma in the UK
Exploring investment trends, licensing deals, and post-Brexit funding opportunities.
Keynote: Meaningful Patient Engagement in Clinical Trials
Moving beyond tokenism to impactful patient involvement.
Keynote: Medical Device Clinical Trials – Regulatory Pathways & Key Considerations
A roadmap to EU & UK submission success, including combination trial challenges.
Keynote: Optimizing Clinical Trial Value in the UK
Insights from the National Contract Value Review (NCVR) initiative.
Join us at COG London 2025 to gain expert insights, expand your network, and discover innovative strategies to optimize your clinical trials. Secure your place today!
Email info@pharmexcel-cro.com
Finding the right CRO for your clinical trial – the five qualities to look for
PHARMExcel awarded for impactful CRO services in ophthalmology clinical trials
Forging paths: a closer look at rare disease clinical trials in the UK
PHARMExcel nominated Best Contract Research Organisation (Specialist Providers) by SCRIP Awards 2024
